abciximab

glycoprotein IIb/IIIa receptor antagonist, is a platelet aggregation inhibitor mainly used during and after coronary artery procedures
Class type of: chemical compound Q307088

Facts

9 properties
🏷️ Also known as
en ReoPro en 7E3 en 7E3 antibody en abciximab en Abciximac en antiGPIIBIIIa en c7E3 en C7E3 en Reopro ar أبسيكسيماب es Abxicimab fa ابسیکسی‌مب fr abciximab (c7e3b fab) id Absiksimab it Abiciximab it C6462H9964N1690O2049S48 ja アブシキシマブ ja アブシキマブ ko 리오프로 ko 압식시맙
🔖 Identifiers · 21
OpenAlex ID
C2777871224
ATC code
B01AC13
ATCvet code
QB01AC13
CAS Registry Number
143653-53-6
ChEMBL ID
CHEMBL1201584
ChemSpider ID
3041712
DeCS ID
57585
Freebase ID
/m/03b6c9
Guide to Pharmacology Ligand ID
6584
HSDB ID
8179
KEGG ID
D02778
MeSH descriptor ID
D000077284
Show all 21 identifiers +9
Microsoft Academic ID (discontinued)
2777871224
NDF-RT ID
N0000148393
OmegaWiki Defined Meaning
1121271
RxNorm CUI
83929
UniChem compound ID
44994870
WikiProjectMed ID
Abciximab
World Health Organisation international non-proprietary name numeric ID
7200

Report an error or request removal Lineage (PROV-JSON)

🔗 Connections
Significant drug interaction 34
← Significant drug interaction 34
Subject has role 3
Medical condition treated 2
← Drug or therapy used for treatment 2
Has characteristic 1
Has use 1
Subclass of 1
Press Enter · cited answer in seconds

Summary

abciximab is a type of chemical entity[1]. abciximab is a type of chemical compound[2].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . DrugBank. wikidata.org.
  3. [4] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  4. [5] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  5. [6] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  6. [7] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  7. [8] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  8. [9] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  9. [10] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  10. [11] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  11. [12] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  12. [13] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  13. [14] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  14. [15] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  15. [16] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  16. [17] ↑ . A reference set of clinically relevant adverse drug-drug interactions. wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . DrugBank. wikidata.org.
  19. [20] ↑ . NDF-RT. Retrieved . wikidata.org.
  20. [21] ↑ . Drug Indications Extracted from FAERS. Retrieved . wikidata.org.
  21. [22] ↑ . NDF-RT. Retrieved . wikidata.org.
  22. [23] ↑ . Medical Subject Headings. Retrieved . wikidata.org.
  23. [24] ↑ . Medical Subject Headings. Retrieved . wikidata.org.
  24. [25] ↑ . DrugBank. wikidata.org.
  25. [26] ↑ . whocc.no. whocc.no. Provenance: wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). abciximab. Retrieved November 15, 2026, from https://4ort.xyz/entity/abciximab
MLA “abciximab.” 4ort.xyz Knowledge Graph, 4ort.xyz, 15 Nov. 2026, https://4ort.xyz/entity/abciximab.
BibTeX @misc{4ortxyz_abciximab_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{abciximab}}, year = {2026}, url = {https://4ort.xyz/entity/abciximab}, note = {Accessed: 2026-11-15}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): abciximab — https://4ort.xyz/entity/abciximab (retrieved 2026-11-15)

Canonical URL: https://4ort.xyz/entity/abciximab · Last refreshed:

Edit History

Rolling log of changes to this entity's Wikidata record. Values shown reflect the current state of each edited property — follow the history link to see the precise diff for any edit.

  1. 13d ago · Elivan da Silva · 2026-11-04 view diff on Wikidata ↗
    Mass → —
    "Removed claim: Mass: 462.149239 dalton, Remoção de massa molecular (P2067) incorreta – abciximab: massa de molécula pequena (CID 3815015), não do Fab (~48 kDa)"
  2. 13d ago · Elivan da Silva · 2026-11-04 view diff on Wikidata ↗
    PubChem CID → —
    "Removed claim: PubChem CID: 3815015, #temporary_batch_1793813972426"
  3. 13d ago · Elivan da Silva · 2026-11-04 view diff on Wikidata ↗
    InChIKey → —
    Canonical SMILES → —
    InChI → —
    Chemical formula → —
    "Removed claim: Chemical formula: C₂₂H₂₇ClN₄O₃S, #temporary_batch_1793813972426"
  4. 13d ago · Elivan da Silva · 2026-11-04 view diff on Wikidata ↗
    UNII → X85G7936GV
    Subject has role → xenobiotic-transporting ATPase inhibitor, anticoagulant, platelet aggregation inhibitors +1
    Significant drug interaction → nabumetone, naproxen, celecoxib +1
    Has use → medication
    + 7 other properties edited (see Wikidata diff for full list)
    "Changed [pt] description: medicamento, #temporary_batch_1793813284429"
Live feed via Wikidata EventStreams. New edits appear within minutes of being made on Wikidata.